Northwestern Mutual Wealth Management
CYTK icon

Northwestern Mutual Wealth Management’s Cytokinetics CYTK Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.21K Sell
79
-464
-85% -$29.5K ﹤0.01% 3296
2025
Q4 		$34.5K Buy
543
+171
+46% +$10.6K ﹤0.01% 2539
2025
Q3 		$20.4K Buy
372
+148
+66% +$6.1K ﹤0.01% 2660
2025
Q2 		$7.4K Buy
224
+159
+245% +$5.53K ﹤0.01% 2886
2025
Q1 		$2.61K Buy
65
+54
+491% +$2.48K ﹤0.01% 3087
2024
Q4 		$517 Buy
+11
New +$571 ﹤0.01% 3381
2024
Q2 		– Sell
-110
Closed -$7.71K – 3553
2024
Q1 		$7.71K Buy
110
+100
+1,000% +$7.73K ﹤0.01% 2711
2023
Q4 		$835 Buy
+10
New +$362 ﹤0.01% 3204
2019
Q2 		– Sell
-40
Closed – – 2536
2019
Q1 		$0 Hold
40
– – ﹤0.01% 2558
2018
Q4 		$0 Buy
+40
New +$293 ﹤0.01% 2432
2015
Q4 		– Sell
-160
Closed -$1K – 1628
2015
Q3 		$1K Buy
+160
New +$1.09K ﹤0.01% 1542

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northwestern Mutual Wealth Management's CYTK Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Cytokinetics (CYTK) stake by 85% in Q1 2026, selling an estimated $29.5K and leaving 79 shares worth $5.21K. The position accounts for ﹤0.01% of the portfolio, ranked #3296.

Northwestern Mutual Wealth Management first reported a position in CYTK in Q3 2015 and has held it in 11 quarters since. The position peaked at $34.5K in Q4 2025. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Northwestern Mutual Wealth Management held 79 shares of Cytokinetics worth $5.21K as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 464 Cytokinetics shares in Q1 2026, an estimated $29.5K.
  • Cytokinetics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3296 holding.
  • Northwestern Mutual Wealth Management first reported a position in Cytokinetics in Q3 2015 and has held it in 11 quarters since.
  • Northwestern Mutual Wealth Management's Cytokinetics position peaked at $34.5K in Q4 2025.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.